Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery

Inclusion Criteria

• •1. Age ≥ 18 years old at index date.
• •2. Diagnosis of Type 2 Diabetes.
• •3. Scheduled for cardiac surgery (coronary artery bypass grafting, valve replacement, ventricular assist device, cardiac transplantation, or any other surgery requiring thoracotomy).
• •4. eGFR ≥ 60 ml/min/1.73 m2.
• •5. Patients who agree to receive treatment with SGLT2 inhibitors.
• •6. Patients must be on current stable hemodynamic profile , without dehydration.